Astec LifeSciences Limited (ASTEC.NS)
INR 705.85
(0.11%)
INR 705.85
(0.11%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.91 Billion INR | 44.25% |
| 2022 | 3.4 Billion INR | 22.2% |
| 2021 | 2.78 Billion INR | 49.21% |
| 2020 | 1.86 Billion INR | 89.89% |
| 2019 | 984.03 Million INR | -43.92% |
| 2018 | 1.75 Billion INR | 41.22% |
| 2017 | 1.24 Billion INR | 0.56% |
| 2016 | 1.23 Billion INR | 12.26% |
| 2015 | 1.1 Billion INR | 40.05% |
| 2014 | 785.85 Million INR | 9.01% |
| 2013 | 720.88 Million INR | 13.6% |
| 2012 | 634.59 Million INR | -5.05% |
| 2011 | 668.37 Million INR | 64.99% |
| 2010 | 405.1 Million INR | 16.12% |
| 2009 | 348.85 Million INR | -18.64% |
| 2008 | 428.79 Million INR | 35.78% |
| 2007 | 315.8 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 5 Billion INR | 106032.62% |
| 2024 Q1 | 4.71 Million INR | -99.9% |
| 2023 Q3 | 4.96 Billion INR | 15.28% |
| 2023 Q2 | 4.3 Billion INR | 90868.31% |
| 2023 FY | 4.91 Billion INR | 44.25% |
| 2023 Q4 | 4.91 Billion INR | -1.0% |
| 2023 Q1 | 4.73 Million INR | -99.86% |
| 2022 Q4 | 3.4 Billion INR | 354.69% |
| 2022 Q3 | 749.3 Million INR | -76.64% |
| 2022 FY | 3.4 Billion INR | 22.2% |
| 2022 Q1 | 5.54 Million INR | -99.8% |
| 2022 Q2 | 3.2 Billion INR | 57753.36% |
| 2021 Q3 | 15.91 Million INR | -99.15% |
| 2021 Q2 | 1.87 Billion INR | 55184.18% |
| 2021 Q1 | 3.38 Million INR | -99.82% |
| 2021 FY | 2.78 Billion INR | 49.21% |
| 2021 Q4 | 2.78 Billion INR | 17418.13% |
| 2020 Q1 | 3.08 Million INR | -99.69% |
| 2020 FY | 1.86 Billion INR | 89.89% |
| 2020 Q2 | 995.54 Million INR | 32212.3% |
| 2020 Q4 | 1.86 Billion INR | 12615.04% |
| 2020 Q3 | 14.69 Million INR | -98.52% |
| 2019 Q4 | 984.03 Million INR | 6378.6% |
| 2019 Q3 | 15.18 Million INR | -99.27% |
| 2019 Q2 | 2.08 Billion INR | 98053.37% |
| 2019 Q1 | 2.12 Million INR | -99.88% |
| 2019 FY | 984.03 Million INR | -43.92% |
| 2018 Q2 | 1.49 Billion INR | 45111.78% |
| 2018 Q4 | 1.75 Billion INR | 8371.61% |
| 2018 Q3 | 20.71 Million INR | -98.62% |
| 2018 Q1 | 3.31 Million INR | -99.73% |
| 2018 FY | 1.75 Billion INR | 41.22% |
| 2017 Q3 | 32.96 Million INR | -97.27% |
| 2017 FY | 1.24 Billion INR | 0.56% |
| 2017 Q4 | 1.24 Billion INR | 3669.53% |
| 2017 Q2 | 1.2 Billion INR | 4146.07% |
| 2017 Q1 | 28.43 Million INR | -97.67% |
| 2016 Q3 | 80.94 Million INR | -91.99% |
| 2016 Q4 | 1.22 Billion INR | 1409.24% |
| 2016 FY | 1.23 Billion INR | 12.26% |
| 2016 Q2 | 1.01 Billion INR | 1571.22% |
| 2016 Q1 | 60.49 Million INR | -94.5% |
| 2015 FY | 1.1 Billion INR | 40.05% |
| 2015 Q4 | 1.1 Billion INR | 0.0% |
| 2015 Q2 | 947.42 Million INR | 682.24% |
| 2015 Q1 | 121.11 Million INR | -84.59% |
| 2014 FY | 785.85 Million INR | 9.01% |
| 2014 Q4 | 785.85 Million INR | 0.0% |
| 2014 Q2 | 694.81 Million INR | 1430.14% |
| 2014 Q1 | 45.4 Million INR | -93.7% |
| 2013 Q4 | 720.88 Million INR | 2010.81% |
| 2013 FY | 720.88 Million INR | 13.6% |
| 2013 Q3 | 34.15 Million INR | -95.73% |
| 2013 Q2 | 800.29 Million INR | 1449.09% |
| 2013 Q1 | 51.66 Million INR | -91.86% |
| 2012 FY | 634.59 Million INR | -5.05% |
| 2012 Q4 | 634.59 Million INR | 194.68% |
| 2012 Q3 | 215.34 Million INR | 0.0% |
| 2011 Q4 | 668.37 Million INR | 0.0% |
| 2011 FY | 668.37 Million INR | 64.99% |
| 2010 FY | 405.1 Million INR | 16.12% |
| 2009 FY | 348.85 Million INR | -18.64% |
| 2008 FY | 428.79 Million INR | 35.78% |
| 2007 FY | 315.8 Million INR | 0.0% |